HomeHYL • EBR
add
Hyloris Pharmaceuticals SA
Previous close
€5.96
Day range
€5.92 - €6.00
Year range
€3.06 - €7.26
Market cap
168.00M EUR
Avg Volume
6.31K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.67M | -28.04% |
Operating expense | 3.37M | -20.43% |
Net income | -1.78M | -2.01% |
Net profit margin | -106.47 | -41.75% |
Earnings per share | — | — |
EBITDA | -1.61M | 11.27% |
Effective tax rate | 4.36% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.12M | -31.61% |
Total assets | 37.05M | -18.45% |
Total liabilities | 8.16M | -24.25% |
Total equity | 28.89M | — |
Shares outstanding | 27.35M | — |
Price to book | 5.62 | — |
Return on assets | -11.89% | — |
Return on capital | -14.42% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.78M | -2.01% |
Cash from operations | -1.67M | 0.36% |
Cash from investing | -656.50K | -440.16% |
Cash from financing | -82.50K | -1,962.50% |
Net change in cash | -2.49M | -67.31% |
Free cash flow | -1.11M | 30.52% |
About
Founded
2012
Website
Employees
50
